EGRX reports results for 3-month “stub” period ending 12/31/14 (see #msg-110060860): http://www.sec.gov/Archives/edgar/data/827871/000082787115000011/eaglestubperiodrelease02-1.htm Cash on hand at 12/31/14 was $34.9M. No quarterly CC insofar as EGRX held a CC for the Treanda deal with Teva this morning.